SEC Form 4 · accession 0001104659-15-000852
MARINUS PHARMACEUTICALS INC · MRNS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Albena Patroneva
Officer — Chief Medical Officer
Period of report
Dec 31, 2014
Accepted (ET)
Jan 7, 2015 · 6:03 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001267813
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee stock option (right to buy)F1 | $10.57 | Dec 31, 2014 | A | 158,000 | A | — | Dec 31, 2024 | Common Stock | 158,000 | 158,000 | D |
Explanation of responses
- F1Options to purchase 39,500 shares vest on 12/31/15; remaining options to purchase shares vest in equal monthly installments at the end of each of the 36 months after 12/31/15.